Cash from Investing (Quarterly) Chart

View Cash from Investing (Quarterly) for COO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Investing (Quarterly) Chart
Start Trial

Historical Cash from Investing (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
April 30, 2026 -90.00M
January 31, 2026 -102.90M
October 31, 2025 -98.80M
July 31, 2025 -98.10M
April 30, 2025 -79.20M
January 31, 2025 -96.80M
October 31, 2024 -241.60M
July 31, 2024 -124.10M
April 30, 2024 -74.80M
January 31, 2024 -324.10M
October 31, 2023 -160.80M
July 31, 2023 -92.90M
April 30, 2023 -82.00M
January 31, 2023 -113.30M
October 31, 2022 -99.70M
July 31, 2022 -46.50M
April 30, 2022 -15.70M
January 31, 2022 -1.669B
October 31, 2021 -66.00M
July 31, 2021 -107.60M
April 30, 2021 -141.00M
January 31, 2021 -135.70M
October 31, 2020 -143.20M
July 31, 2020 -51.80M
April 30, 2020 -91.10M
Date Value
January 31, 2020 -78.40M
October 31, 2019 -84.90M
July 31, 2019 -83.70M
April 30, 2019 -53.50M
January 31, 2019 -129.20M
October 31, 2018 -46.50M
July 31, 2018 -52.40M
April 30, 2018 -174.00M
January 31, 2018 -1.245B
October 31, 2017 -88.90M
July 31, 2017 -61.30M
April 30, 2017 -29.00M
January 31, 2017 -202.10M
October 31, 2016 -50.08M
July 31, 2016 -136.95M
April 30, 2016 -125.73M
January 31, 2016 -106.03M
October 31, 2015 -102.06M
July 31, 2015 -66.77M
April 30, 2015 -53.92M
January 31, 2015 -65.20M
October 31, 2014 -1.171B
July 31, 2014 -56.07M
April 30, 2014 -61.63M
January 31, 2014 -58.13M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Globus Medical, Inc. -129.05M
West Pharmaceutical Services, Inc. -43.20M
Stryker Corp. -639.00M
Solventum Corp. -87.00M
Innovative Eyewear, Inc. -0.0265M